Immuneering IMRX
NASDAQ IMRX
$3.73 -0.08 (-2.10%)
At close: Oct 23, 2026 · 4:00 PM EDT

Immuneering (IMRX) Sale and Maturity of Investments (2022 - 2026)

Updated

Analysis

Immuneering (IMRX) Sale and Maturity of Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Immuneering 241.32 Mn -465.67 Mn - 22.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.50 Mn
Mar 31, 2026 9.00 Mn
Dec 31, 2024 5.50 Mn
Jun 30, 2024 5.00 Mn
Mar 31, 2024 21.43 Mn
Dec 31, 2023 19.05 Mn
Sep 30, 2023 5.00 Mn
Jun 30, 2023 9.25 Mn
Mar 31, 2023 19.00 Mn
Dec 31, 2022 20.60 Mn
Sep 30, 2022 19.25 Mn
Jun 30, 2022 32.33 Mn
Mar 31, 2022 20.50 Mn
API Access

Immuneering Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=IMRX&period=max&api_key=YOUR_API_KEY